Takeuchi K, Yagi K, Kato S, Ukawa H
Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Yamashina, Japan.
Gastroenterology. 1997 Nov;113(5):1553-9. doi: 10.1053/gast.1997.v113.pm9352857.
BACKGROUND & AIMS: Receptors activated by prostaglandin (PG) E2 are pharmacologically subdivided into four subtypes (EP1-EP4). The EP-receptor subtype(s) involved in stimulation of gastroduodenal HCO3- secretion in rats were investigated.
Under urethane anesthesia, a stomach mounted in an ex vivo chamber or a proximal duodenal loop was perfused with saline, and HCO3- secretion was measured using a pH-stat method.
Intravenous PGE2 increased HCO3- secretion by the gastroduodenal mucosa; this action was verapamil sensitive and, only in the duodenum, potentiated by isobutylmethyl xanthine (IBMX). Duodenal HCO3- secretion was stimulated by enprostil, sulprostone (EP1/EP3 agonist), misoprostol (EP2/EP3 agonist), and ONO-NT012 (EP3 agonist) but was not affected by butaprost (EP2 agonist) or 17-phenyl-PGE2 (EP1 agonist). Gastric HCO3- secretion was stimulated by sulprostone, enprostil, and 17-phenyl-PGE2 but not by misoprostol, butaprost, or ONO-NT012. SC-51089 (EP1 antagonist) inhibited the HCO3--stimulatory action of sulprostone only in the stomach. IBMX potentiated the HCO3- response to sulprostone in the duodenum, whereas verapamil reduced the response in both the stomach and duodenum.
PGE stimulates HCO3- secretion via different EP-receptor subtypes in the stomach and duodenum: in the stomach, EP1 receptors are linked to Ca2+; in the duodenum, EP3 receptors are coupled with both adenosine 3', 5'-cyclic monophosphate and Ca2+.
前列腺素(PG)E2激活的受体在药理学上可细分为四种亚型(EP1 - EP4)。本研究旨在探究参与刺激大鼠胃十二指肠HCO3-分泌的EP受体亚型。
在氨基甲酸乙酯麻醉下,将置于离体腔室中的胃或十二指肠近端肠袢用生理盐水灌注,采用pH计法测量HCO3-分泌。
静脉注射PGE2可增加胃十二指肠黏膜的HCO3-分泌;该作用对维拉帕米敏感,且仅在十二指肠中,异丁基甲基黄嘌呤(IBMX)可增强此作用。十二指肠HCO3-分泌受到恩前列素、硫前列酮(EP1/EP3激动剂)、米索前列醇(EP2/EP3激动剂)和ONO - NT012(EP3激动剂)的刺激,但不受丁咯前列素(EP2激动剂)或17 - 苯基 - PGE2(EP1激动剂)的影响。胃HCO3-分泌受到硫前列酮、恩前列素和17 - 苯基 - PGE2的刺激,但不受米索前列醇、丁咯前列素或ONO - NT012的影响。SC - 51089(EP1拮抗剂)仅在胃中抑制硫前列酮对HCO3-的刺激作用。IBMX增强了十二指肠对硫前列酮的HCO3-反应,而维拉帕米降低了胃和十二指肠的反应。
PGE通过胃和十二指肠中不同的EP受体亚型刺激HCO3-分泌:在胃中,EP1受体与Ca2+相关;在十二指肠中,EP3受体与腺苷3',5'-环磷酸单酯和Ca2+均有关联。